Literature DB >> 4952914

Intensive combination chemotherapy and X-irradiation in Hodgkin's disease.

J H Moxley, V T De Vita, K Brace, E Frei.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 4952914

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  10 in total

1.  Tumor-Targeted Synergistic Blockade of MAPK and PI3K from a Layer-by-Layer Nanoparticle.

Authors:  Erik C Dreaden; Yi Wen Kong; Stephen W Morton; Santiago Correa; Ki Young Choi; Kevin E Shopsowitz; Kasper Renggli; Ronny Drapkin; Michael B Yaffe; Paula T Hammond
Journal:  Clin Cancer Res       Date:  2015-06-01       Impact factor: 12.531

Review 2.  Therapeutic drug monitoring in oncology. Problems and potential in antineoplastic therapy.

Authors:  M J Moore; C Erlichman
Journal:  Clin Pharmacokinet       Date:  1987-10       Impact factor: 6.447

3.  Coordinated effects of microRNA-494 induce G₂/M arrest in human cholangiocarcinoma.

Authors:  Sumitaka Yamanaka; Nathaniel R Campbell; Fangmei An; Scot C Kuo; James J Potter; Esteban Mezey; Anirban Maitra; Florin M Selaru
Journal:  Cell Cycle       Date:  2012-07-15       Impact factor: 4.534

Review 4.  Hybrid Drugs-A Strategy for Overcoming Anticancer Drug Resistance?

Authors:  Marta Szumilak; Anna Wiktorowska-Owczarek; Andrzej Stanczak
Journal:  Molecules       Date:  2021-04-29       Impact factor: 4.411

5.  Is it time for a new paradigm for systemic cancer treatment? Lessons from a century of cancer chemotherapy.

Authors:  Sarah Crawford
Journal:  Front Pharmacol       Date:  2013-06-25       Impact factor: 5.810

Review 6.  How Chemotherapy Increases the Risk of Systemic Candidiasis in Cancer Patients: Current Paradigm and Future Directions.

Authors:  Flora Teoh; Norman Pavelka
Journal:  Pathogens       Date:  2016-01-15

Review 7.  Drug Combination in Cancer Treatment-From Cocktails to Conjugated Combinations.

Authors:  Yosi Gilad; Gary Gellerman; David M Lonard; Bert W O'Malley
Journal:  Cancers (Basel)       Date:  2021-02-07       Impact factor: 6.639

8.  Assessment of the evolution of cancer treatment therapies.

Authors:  Manuel Arruebo; Nuria Vilaboa; Berta Sáez-Gutierrez; Julio Lambea; Alejandro Tres; Mónica Valladares; Africa González-Fernández
Journal:  Cancers (Basel)       Date:  2011-08-12       Impact factor: 6.639

Review 9.  Evolution of Cancer Pharmacological Treatments at the Turn of the Third Millennium.

Authors:  Luca Falzone; Salvatore Salomone; Massimo Libra
Journal:  Front Pharmacol       Date:  2018-11-13       Impact factor: 5.810

Review 10.  Nanocluster-Based Drug Delivery and Theranostic Systems: Towards Cancer Therapy.

Authors:  Alma Lucia Villela Zumaya; Rosica Mincheva; Jean-Marie Raquez; Fatima Hassouna
Journal:  Polymers (Basel)       Date:  2022-03-16       Impact factor: 4.329

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.